Health and Fitness Health and Fitness
Tue, March 8, 2011
Mon, March 7, 2011
Sat, March 5, 2011
Fri, March 4, 2011
Thu, March 3, 2011
Wed, March 2, 2011
[ Wed, Mar 02nd 2011 ] - Market Wire
BURCON AMENDS LETTER OF INTENT
Tue, March 1, 2011
Mon, February 28, 2011
Sun, February 27, 2011
Fri, February 25, 2011
Thu, February 24, 2011
Wed, February 23, 2011
Tue, February 22, 2011
[ Tue, Feb 22nd 2011 ] - Market Wire
PROTOX APPOINTS NEW DIRECTORS
Mon, February 21, 2011
Sun, February 20, 2011
Fri, February 18, 2011
Thu, February 17, 2011

AngioDynamics Cancels Participation in 2011 RBC Capital Markets Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. 1-rbc-capital-markets-healthcare-conference.html
Published in Health and Fitness on Friday, February 25th 2011 at 14:25 GMT by Market Wire   Print publication without navigation


ALBANY, N.Y.--([ BUSINESS WIRE ])--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that Joseph Gersuk, Executive Vice President and Chief Financial Officer, will not be able to present at the RBC Capital Markets Healthcare Conference on Wednesday, March 2, 2011, due to minor injuries sustained in a recent accident.

"This development combined with a scheduling conflict that prevents my participation leads us to cancel our scheduled presentation at the RBC healthcare conference."

aWhile Joe remains able to fulfill his daily responsibilities as CFO, he recently sustained minor injuries in an accident that prevent him from traveling,a said Jan Keltjens, AngioDynamics President and CEO. aThis development combined with a scheduling conflict that prevents my participation leads us to cancel our scheduled presentation at the RBC healthcare conference.a

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamicsa™ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at [ www.angiodynamics.com ].


Publication Contributing Sources